Analysed EVOGENE LTD (EVGN:NASDAQ) News Sources
Evogene to Present Its Pharma Division Achievements at the BIO International Convention
09-06-2026
yahoo.com
Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI™ Toward Autonomous Small Molecule Discovery and Optimization
24-06-2026
yahoo.com
Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery
08-07-2026
yahoo.com
Evogene and Tel Aviv University launch drug discovery initiative
09-07-2026
pharmaceutical-technology.com
AgPlenus Launches Novel AI Model for Predicting Antifungal Potency, Expanding ChemPass AI for Ag™ Capabilities
15-07-2026
yahoo.com
Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection – Downloadable Initiation Report
21-07-2026
yahoo.com
Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection
21-07-2026
yahoo.com
Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular Diseases
22-07-2026
yahoo.com
What is the current price of EVOGENE LTD (EVGN:NASDAQ)?
The current price of EVOGENE LTD (EVGN:NASDAQ) is $0.471.
EVOGENE LTD (EVGN:NASDAQ) absolute price change since previous trading day?
The absolute price change of EVOGENE LTD (EVGN:NASDAQ) since the previous trading day is $-0.0184.
EVOGENE LTD (EVGN:NASDAQ) percentage price change since previous trading day?
The percentage price change of EVOGENE LTD (EVGN:NASDAQ) since the previous trading day is -3.7597%.
What is the most recent average sentiment score for EVOGENE LTD (EVGN:NASDAQ)?
The most recent average sentiment score for EVOGENE LTD (EVGN:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for EVOGENE LTD (EVGN:NASDAQ)?
The most recent sentiment for EVOGENE LTD (EVGN:NASDAQ) is .
SEC-8K** Filing Available For EVOGENE LTD (EVGN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.